STAAR OVARIAN CANCER

EIN: 844672869 501(c)(3) Medical Research

CHICAGO, IL

Total Revenue
$399,588
Total Expenses
$277,067
Total Assets
$448,000
Net Assets
$148,848
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2020
Legal Domicile
IL
Principal Officer
NICOLE ANDREWS
Phone
2819239051
Tax Period
2023-01-01 to 2023-12-31

STAAR OVARIAN CANCER, founded in 2020, is a small nonprofit in the Medical Research sector that reported $400K in total revenue in fiscal year 2023. Revenue surged 29% from the prior year, signaling strong growth momentum. The organization ran a surplus of $123K, a strong 31% operating margin.

Mission

STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.

Program Service Accomplishments

Program 1
Expenses: $44,670

CONTINUING SUPPORTING AND EXPANDING AN AWARENESS CAMPAIGN OF LGSOC.

Program 2
Expenses: $153,000

AWARDED RESEARCH GRANTS FOR LGSOC

Program 3
Expenses: $79,397 Revenue: $71,500

CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT...

Read more

CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT FOCUSED DRUG DEVELOPMENT MEETING AS DIRECTED BY THE US FDA FOR PATIENTS TO PRESENT THEIR PERSPECTIVES ON LIVING WITH THEIR RARE DISEASE AND THEIR DAILY LIFE WITH THE CURRENT TREATMENTS. PROVIDE A PLATFORM FOR PATIENTS TO SHARE THEIR THOUGHTS ON DRUG DEVELOPMENT AND SIDE EFFECTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $327,751
Program Service Revenue $71,500
Investment Income $337
Other Revenue $0
TOTAL REVENUE $399,588

Expense Breakdown

Grants Paid $153,000
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $277,067
Other Expenses $124,067
TOTAL EXPENSES $277,067

Year-over-Year Comparison

2023 2022 Change
Revenue $399,588 $310,800 +0.3%
Expenses $277,067 $513,766 -0.5%
Net Income $122,521 $-202,966 -1.6%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
9
Independent Members
9
Employees
N/A
Volunteers
15

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
6
$0
Total Directors
3
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ELLIE HABIB DIRECTOR 2.00
Director
$0 $0 $0
MADALYN KENNEY DIRECTOR 1.00
Director
$0 $0 $0
BAILEY WOLFE DIRECTOR 1.00
Director
$0 $0 $0
NICOLE ANDREWS CHAIR 10.00
Officer
$0 $0 $0
CHRISTINA CAMPBELL TREASURER 2.00
Officer
$0 $0 $0
MORGAN GAYNOR SECRETARY 2.00
Officer
$0 $0 $0
KARI NEUMEYER V-CHAIR MARK 2.00
Officer
$0 $0 $0
EMMA SCHLAMM DIRECTOR 2.00
Officer
$0 $0 $0
ALYSSA TOOMES V-CHAIR FUND 2.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $399,588 $277,067 $448,000 $122,521
2022 $310,800 $513,766 $164,305 $-202,966
Explore More Nonprofits
Top 100 Nonprofits in Illinois Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare STAAR OVARIAN CANCER with other nonprofits in Illinois and across the country.